OSTERTAG ERIC (Chief Executive Officer) sold 11.1% of their position (20K shares) of POSEIDA THERAPEUTICS, INC. on the open market
Open‑market sale worth $160.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/22/2021ACC: 0001209191-21-057289
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2020
-20K
Net shares
Net seller
$160.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
20K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−20K
Price / share
$8.00
Trade value
$160.02K
% of position
11.1%
9/20/2021
180.70K→160.70K
Total
Net shares
−20K
Net value
-$160.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/20/2021 | S · Sale | −20K | $8.00 | $160.02K | 11.1% | 180.70K | 160.70K |
| Total | −20K | -$160.02K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)5
Common Stock
DirectShares owned675.41K
Common Stock
IndirectShares owned961.45K
Common Stock
IndirectShares owned3.38M
Common Stock
IndirectShares owned3.68M
Common Stock
IndirectShares owned629.19K
Total
675.41K direct·8.65M indirect9.32M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 675.41K | Direct |
| Common Stock | 961.45K | Indirect |
| Common Stock | 3.38M | Indirect |
| Common Stock | 3.68M | Indirect |
| Common Stock | 629.19K | Indirect |
| Total | 9.32M | 675.41K direct·8.65M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported